Zusammenfassung
Die Bedeutung der Lebensqualität hat in den letzten Jahrzehnten im medizinischen Denken stark an Bedeutung gewonnen und ist neben dem Langzeitüberleben zum zweitwichtigsten Pfeiler und Parameter in der Gesamtbeurteilung für das Outcome eines Patienten geworden. Patienten mit Lungenkarzinom können in Abhängigkeit ihres Tumorstadiums sowohl in der Prognose als auch in der Symptomatik der Erkrankung ganz erhebliche Unterschiede aufweisen, die die individuelle Qualität des Lebens fundamental beeinflussen. Qualität ist jedoch ein abstrakter Begriff und deren Messung schwierig. Für die Erfassung der Lebensqualität von Lungenkarzinompatienten wurden deshalb von der European Organisation for Research and Treatment of Cancer (EORTC) die Standardfragebögen QLQ-C30 und QLQ-LC13 entwickelt, die sich in den letzten 20 Jahren als klinisch relevant und für die Bewertung nützlich erwiesen haben. In Metaanalysen wurde die präoperative exspiratorische Einsekundenkapazität (FEV1) der Patienten als negativer prädiktiver Wert für eine reduzierte Lebensqualität identifiziert. Das Alter des Patienten spielt hingegen für die Prognose der Lebensqualität keine Rolle. Um den unmittelbaren postoperativen negativen Effekt der Operation auf die Lebensqualität weiter zu minimieren, hat die Thoraxchirurgie in den letzten Jahrzehnten durch technische Neuerungen (videoassistierte Thoraxchirurgie [VATS], Roboterchirurgie) wesentliche Fortschritte unternommen.
Abstract
Over the past decades the quality of life has become increasingly more important in medical trains of thought and apart from long-term survival has become the second most important cornerstone and parameter in the total assessment for the outcome of patients. Patients with lung cancer can show substantial differences in the prognosis and the symptoms of the disease depending on the tumor stage, which fundamentally influence the individual quality of life; however, quality of life is an abstract term and measurement is difficult. The standard questionnaires QLQ-C30 and QLQ-LC13 of the European Organisation for Research and Treatment of Cancer (EORTC) were therefore developed for collation of the quality of life of lung cancer patients, which over the last 20 years have proven to be clinically relevant and useful for the assessment. In meta-analyses the preoperative forced expiratory volume in 1 s (FEV1) was identified as having a negative predictive value for a reduced quality of life. In contrast, the age of patients does not play any role in the prognosis on the quality of life. In order to further minimize the immediately postoperative negative effect of the operation on the quality of life, in recent decades thoracic surgery has undergone substantial progress by the introduction of novel techniques, such as video-assisted thoracic surgery (VATS).
Abbreviations
- DASS-21:
-
Depression Anxiety Stress Scales-21
- EORTC:
-
European Organization for Research and Treatment of Cancer
- FACT-L:
-
Functional Assessment of Cancer Therapy-Lung
- FEV1 :
-
Forcierte end-expiratorische Vitalkapazität in 1 s
- HD:
-
High Definition
- LCSS:
-
Lung Cancer Symptom Scale
- NSCLC:
-
Non small cell lung cancer (Nicht-kleinzelliges Lungenkarzinom)
- PCS:
-
Physical Composite Score (Wertemittlung des SF-12)
- QoL:
-
Quality of Life (Lebensqualität)
- QLQ:
-
Quality of Life Questionnaire
- RS:
-
Robotic Surgery
- SF-12:
-
Short-form 12 health survey (Kurzform des SF-36)
- SF-36:
-
Short-form 36 health survey
- VATS:
-
Video-assisted Thoracic Surgery
- 3D:
-
Dreidimensional
Literatur
Siegel R, DeSantis C, Virgo K et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62(4):220–241
Cykert S, Kissling G, Hansen CJ (2000) Patient preferences regarding possible outcomes of lung resection: what outcomes should preoperative evaluations target? Chest 117(6):1551–1559
McManus K (2003) Concerns of poor quality of life should not deprive patients of the opportunity of curative surgery. Thorax 58(3):189
Brunelli A, Berrisford RG, Rocco G, Varela G (2009) European Society of Thoracic Surgeons Database Committee. The European Thoracic Database project: composite performance score to measure quality of care after major lung resection. Eur J Cardiothorac Surg 35(5):769–774
Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
Henry JD, Crawford JR (2005) The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large clinical sample. Br J Clin Psychol 44:227–239
Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR (2001) Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 31(2–3):233–240
Montazeri A (2009) Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 23(7):102
Koller M, Warncke S, Hjermstad MJ, Arraras J, Pompili C, Harle A, Johnson CD, Chie WC, Schulz C, Zeman F, Meerbeeck JP van, Kuliś D, Bottomley A, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group, European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group (2015) Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development. Cancer 121(24):4300–4323
Fayers PM, Aaronson NK, Bjordal K, EORTC Quality of Life Group et al (2001) The EORTC QLQ-C30 scoring manual, 3. Aufl. European Organisation for Research and Treatment of cancer, Brussels
Zitzler N, Schulz C, Hofmann SH, Hipp M, Bohrer T, Lindberg P, Klinkhammer-Schalke M, Pfeifer M, Wiese C, Hjermstad JM, Pompili C, Koller M, EORTC QLG Arbeitsgruppe Lungenkarzinom (2011) Messung der Lebensqualität bei Patienten mit Lungenkarzinom. Dtsch Z Onkol 41:1–6
Nilges P, Essau C (2015) Depression, anxiety and stress scales: DASS-A screening procedure not only for pain patients. Schmerz 29(6):649–657
Schulte T, Schniewind B, Dohrmann P, Küchler T, Kurdow R (2009) The extent of lung parenchyma resection significantly impacts long-term quality of life in patients with non-small cell lung cancer. Chest 135(2):322–329
Xie D, Deschamps C, Shen RK, Deng B, Wampfler JA, Cassivi SD, Nichols FC, Allen MS, Wigle DA, Yang P (2015) Bilobectomy versus Lobectomy for non-small cell lung cancer: A comparative study of outcomes, long-term survival, and quality of life. Ann Thorac Surg 100(1):242–250
Elshorbagy A et al (2015) Functional outcome and Health-related Quality of life two years after lobectomy and sublobectomy for early stage non-small cell lung cancer: A New Center Experience. J Cardiothorac Surg 10(Suppl 1):A29
Hanna JM, Berry MF, D’Amico TA (2013) Contraindications of video-assisted thoracoscopic surgical lobectomy and determinants of conversion to open. J Thorac Dis 5(Suppl 3):182–189
Falcoz PE, Puyraveau M, Thomas PA, Decaluwe H, Hürtgen M, Petersen RH, Hansen H, Brunelli A, ESTS Database Committee, ESTS Minimally Invasive Interest Group (2016) Video-assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer: a propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database. Eur J Cardiothorac Surg 49(2):602–609 (Feb)
Oparka J, Yan TD, Ryan E, Dunning J (2013) Does video-assisted thoracic surgery provide a safe alternative to conventional techniques in patients with limited pulmonary function who are otherwise suitable for lung resection? Interact Cardiovasc Thorac Surg 17(1):159–162
Liu C, Li Z, Bai C, Wang L, Shi X, Song Y (2015) Video-assisted thoracoscopic surgery and thoracotomy during lobectomy for clinical stage I non-small-cell lung cancer have equivalent oncological outcomes: A single-center experience of 212 consecutive resections. Oncol Lett 9(3):1364–1372
Zhao J, Zhao Y, Qiu T, Jiao W, Xuan Y, Wang X, Wang Y, Luo Y (2015) Quality of life and survival after II stage nonsmall cell carcinoma surgery: Video-assisted thoracic surgery versus thoracotomy lobectomy. Indian J Cancer 52(Suppl 2):e130–e133
Veronesi G (2015) Robotic lobectomy and segmentectomy for lung cancer: results and operating technique. J Thorac Dis 7(Suppl 2):S122–S130
Park BJ, Melfi F, Mussi A, Maisonneuve P, Spaggiari L, Silva RK da, Veronesi G (2012) Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results. J Thorac Cardiovasc Surg 143(2):383–389
Cao C, Manganas C, Ang SC, Peeceeyen S, Yan TD (2013) Video-assisted thoracic surgery versus open thoracotomy for non-small cell lung cancer: a meta-analysis of propensity score-matched patients. Interact Cardiovasc Thorac Surg 16(3):244–249
Ferguson MK, Parma CM, Celauro AD, Vigneswaran WT (2009) Quality of life and mood in older patients after major lung resection. Ann Thorac Surg 87(4):1007–1013
Birim O, Zuydendorp HM, Maat AP, Kappetein AP, Eijkemans MJ, Bogers AJ (2003) Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population. Ann Thorac Surg 76(6):1796–1801
Limmer S, Hauenschild L, Eckmann C et al (2009) Thoracic surgery in the elderly – co-morbidity is the limit. Interact Cardiovasc Thorac Surg 8(4):412–416
Cannon J, Win T (2008) Long-term quality of life after lung resection. Thorac Surg Clin 18(1):81–91
Gebretsadik M, Jayaprabhu S, Grossberg GT (2006) Mood disorders in the elderly. Med Clin North Am 90(5):789–805
Chambers A, Routledge T, Pilling J, Scarci M (2010) In elderly patients with lung cancer is resection justified in terms of morbidity, mortality and residual quality of life? Interact Cardiovasc Thorac Surg 10(6):1015–1021
Varela G, Novoa N, Jiménez MF (2000) Influence of age and predicted forced expiratory volume in 1 s on prognosis following complete resection for non-small cell lung carcinoma. Eur J Cardiothorac Surg 18(1):2–6
Möller A, Sartipy U (2012) Associations between changes in quality of life and survival after lung cancer surgery. J Thorac Oncol 7(1):183–187
Pompili C (2015) Quality of life after lung resection for lung cancer. J Thorac Dis 7(Suppl 2):S138–S144
Fernando HC, Landreneau RJ, Mandrekar SJ, Nichols FC, DiPetrillo TA, Meyers BF, Heron DE, Hillman SL, Jones DR, Starnes SL, Tan AD, Daly BD, Putnam JB, Alliance for Clinical Trials in Oncology (2015) Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trial. J Thorac Cardiovasc Surg 149(3):718–726 (discussion 725–6)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
S. Limmer gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Additional information
Redaktion
B. Jany, Würzburg
Rights and permissions
About this article
Cite this article
Limmer, S. Outcome und Lebensqualität nach resezierenden lungenchirurgischen Verfahren beim Lungenkarzinom. Pneumologe 13, 233–240 (2016). https://doi.org/10.1007/s10405-016-0048-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10405-016-0048-z